BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Asselah T, Durantel D, Pasmant E, Lau G, Schinazi RF. COVID-19: Discovery, diagnostics and drug development. J Hepatol. 2021;74:168-184. [PMID: 33038433 DOI: 10.1016/j.jhep.2020.09.031] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 29.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Lan P, Yi J, Yang C, Gong X, Ge H, Xu X, Liu L, Zhou J, Lv F. Secondary bloodstream infection in critically ill patients with COVID-19. J Int Med Res 2021;49:3000605211062783. [PMID: 34898307 DOI: 10.1177/03000605211062783] [Reference Citation Analysis]
2 de Carvalho FO, Silva JPR, Silva ÉR, de Albuquerque Júnior RLC, Nunes PS, de Souza Araújo AA. Would carvacrol be a supporting treatment option effective in minimizing the deleterious effects of COVID-19? Naunyn Schmiedebergs Arch Pharmacol 2021;394:2471-4. [PMID: 34669001 DOI: 10.1007/s00210-021-02170-7] [Reference Citation Analysis]
3 N JB, Goudgaon N. A comprehensive review on pyrimidine analogs-versatile scaffold with medicinal and biological potential. Journal of Molecular Structure 2021;1246:131168. [DOI: 10.1016/j.molstruc.2021.131168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
4 [DOI: 10.1101/2021.02.20.432110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Shen T, Wang T. Metabolic Reprogramming in COVID-19. Int J Mol Sci 2021;22:11475. [PMID: 34768906 DOI: 10.3390/ijms222111475] [Reference Citation Analysis]
6 Yang Y, Ding L, Bao T, Li Y, Ma J, Li Q, Gao Z, Song S, Wang J, Zhao J, Wang Z, Zhao D, Li X, Wang Z, Zhao L, Tong X. Network Pharmacology and Experimental Assessment to Explore the Pharmacological Mechanism of Qimai Feiluoping Decoction Against Pulmonary Fibrosis. Front Pharmacol 2021;12:770197. [PMID: 34925028 DOI: 10.3389/fphar.2021.770197] [Reference Citation Analysis]
7 Bian Y, Le Y, Du H, Chen J, Zhang P, He Z, Wang Y, Yu S, Fang Y, Yu G, Ling J, Feng Y, Wei S, Huang J, Xiao L, Zheng Y, Yu Z, Li S. Efficacy and Safety of Anticoagulation Treatment in COVID-19 Patient Subgroups Identified by Clinical-Based Stratification and Unsupervised Machine Learning: A Matched Cohort Study. Front Med (Lausanne) 2021;8:786414. [PMID: 35004751 DOI: 10.3389/fmed.2021.786414] [Reference Citation Analysis]
8 Rotondo JC, Martini F, Maritati M, Mazziotta C, Di Mauro G, Lanzillotti C, Barp N, Gallerani A, Tognon M, Contini C. SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants. Viruses 2021;13:1687. [PMID: 34578269 DOI: 10.3390/v13091687] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
9 Bai Z, Cao Y, Liu W, Li J. The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation. Viruses 2021;13:1115. [PMID: 34200602 DOI: 10.3390/v13061115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Jiaranaikulwanitch J, Yooin W, Chutiwitoonchai N, Thitikornpong W, Sritularak B, Rojsitthisak P, Vajragupta O. Discovery of Natural Lead Compound from Dendrobium sp. against SARS-CoV-2 Infection. Pharmaceuticals 2022;15:620. [DOI: 10.3390/ph15050620] [Reference Citation Analysis]
11 Zhou X, Ye Q. Cellular Immune Response to COVID-19 and Potential Immune Modulators. Front Immunol 2021;12:646333. [PMID: 33995364 DOI: 10.3389/fimmu.2021.646333] [Reference Citation Analysis]
12 Farzana M, Shahriar S, Jeba FR, Tabassum T, Araf Y, Ullah MA, Tasnim J, Chakraborty A, Naima TA, Marma KKS, Rahaman TI, Hosen MJ. Functional food: complementary to fight against COVID-19. Beni-Suef Univ J Basic Appl Sci 2022;11. [DOI: 10.1186/s43088-022-00217-z] [Reference Citation Analysis]
13 Yang L, Wang Z. Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer. Biomedicines 2021;9:689. [PMID: 34207313 DOI: 10.3390/biomedicines9060689] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Sun F, Wang X, Tan S, Dan Y, Lu Y, Zhang J, Xu J, Tan Z, Xiang X, Zhou Y, He W, Wan X, Zhang W, Chen Y, Tan W, Deng G. SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants. Microbiol Spectr 2021;9:e0026121. [PMID: 34346744 DOI: 10.1128/Spectrum.00261-21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Ni Y, Zeng H, Song X, Zheng J, Wu H, Liu C, Zhang Y. Potential metal-related strategies for prevention and treatment of COVID-19. Rare Met . [DOI: 10.1007/s12598-021-01894-y] [Reference Citation Analysis]
16 Lu T, Xu R, Wang C, Zhao J, Peng B, Wang J, Zhang L. Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development. Front Genet 2022;13:853113. [DOI: 10.3389/fgene.2022.853113] [Reference Citation Analysis]
17 Vedova-costa JMD, Ramos ELP, Boschero RA, Ferreira GN, Soccol VT, Santiani MH, Pacce VD, Lustosa BPR, Vicente VA, Soccol CR. A Review on COVID-19 Diagnosis Tests Approved for Use in Brazil and the Impact on Pandemic Control. Braz arch biol technol 2021;64:e21200147. [DOI: 10.1590/1678-4324-75years-2021200147] [Reference Citation Analysis]
18 Mathieu C, Touret F, Jacquemin C, Janin YL, Nougairède A, Brailly M, Mazelier M, Décimo D, Vasseur V, Hans A, Valle-Casuso JC, de Lamballerie X, Horvat B, André P, Si-Tahar M, Lotteau V, Vidalain PO. A Bioluminescent 3CLPro Activity Assay to Monitor SARS-CoV-2 Replication and Identify Inhibitors. Viruses 2021;13:1814. [PMID: 34578395 DOI: 10.3390/v13091814] [Reference Citation Analysis]
19 Mohamadi Yarijani Z, Najafi H. Kidney injury in COVID-19 patients, drug development and their renal complications: Review study. Biomed Pharmacother 2021;142:111966. [PMID: 34333286 DOI: 10.1016/j.biopha.2021.111966] [Reference Citation Analysis]
20 Payberah E, Payberah D, Sarangi A, Gude J. COVID-19 vaccine hesitancy in patients with mental illness: strategies to overcome barriers—a review. J Egypt Public Health Assoc 2022;97. [DOI: 10.1186/s42506-022-00102-8] [Reference Citation Analysis]
21 Yadav DK, Singh DD, Han I, Kumar Y, Choi EH. Current Potential Therapeutic Approaches against SARS-CoV-2: A Review. Biomedicines 2021;9:1620. [PMID: 34829850 DOI: 10.3390/biomedicines9111620] [Reference Citation Analysis]
22 Boyesen EO, Balsby IM, Henriksen M, Christensen R, Rasmussen JH, Nielsen FE, Nygaard H, Friis-Hansen LJ, Nielsen SD, Thudium RF, Porsberg C, Kristensen LE, Bliddal H. Triage Strategies Based on C-Reactive Protein Levels and SARS-CoV-2 Tests among Individuals Referred with Suspected COVID-19: A Prospective Cohort Study. J Clin Med 2021;11:201. [PMID: 35011944 DOI: 10.3390/jcm11010201] [Reference Citation Analysis]
23 Fadel C, Phan N, Kaur A. Liberal Intravenous Fluid Administration in a Rare Case of Severe Rhabdomyolysis Secondary to SARS-CoV-2. Cureus 2021;13:e17234. [PMID: 34540461 DOI: 10.7759/cureus.17234] [Reference Citation Analysis]
24 McKay B, Meyers M, Rivard L, Stoltzfus J, Rammohan G, Stankewicz H. Predicting 30 - Day outcomes in emergency department patients discharged with COVID-19. Am J Emerg Med 2021;50:513-7. [PMID: 34537576 DOI: 10.1016/j.ajem.2021.08.077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Dai J, Wang H, Liao Y, Tan L, Sun Y, Song C, Liu W, Qiu X, Ding C. Coronavirus Infection and Cholesterol Metabolism. Front Immunol 2022;13:791267. [DOI: 10.3389/fimmu.2022.791267] [Reference Citation Analysis]
26 Dillon GA, Wolf ST, Alexander LM. Nitric Oxide-mediated Cutaneous Microvascular Function is not Altered in Young Adults Following Mild-to-Moderate SARS CoV-2 Infection. Am J Physiol Heart Circ Physiol 2022. [PMID: 34995164 DOI: 10.1152/ajpheart.00602.2021] [Reference Citation Analysis]
27 Beckman MF, Mougeot FB, Mougeot JC. Comorbidities and Susceptibility to COVID-19: A Generalized Gene Set Data Mining Approach. J Clin Med 2021;10:1666. [PMID: 33924631 DOI: 10.3390/jcm10081666] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Cunha GHD, Siqueira LR, Fontenele MSM, Moreira LA, Ramalho AKL, Fechine FV. Prevalence of testing and coronavirus-19 among nurses in the pandemic. Rev Bras Enferm 2022;75:e20210365. [DOI: 10.1590/0034-7167-2021-0365] [Reference Citation Analysis]
29 Basra R, Whyte M, Karalliedde J, Vas P. What is the impact of microvascular complications of diabetes on severe COVID-19? Microvasc Res 2021;140:104310. [PMID: 34979154 DOI: 10.1016/j.mvr.2021.104310] [Reference Citation Analysis]
30 Ge S, Lu J, Hou Y, Lv Y, Wang C, He H. Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2. Virology 2021;560:110-5. [PMID: 34052578 DOI: 10.1016/j.virol.2021.05.009] [Reference Citation Analysis]
31 Hou P, Wang X, Wang H, Wang T, Yu Z, Xu C, Zhao Y, Wang W, Zhao Y, Chu F, Chang H, Zhu H, Lu J, Zhang F, Liang X, Li X, Wang S, Gao Y, He H. The ORF7a protein of SARS-CoV-2 initiates autophagy and limits autophagosome-lysosome fusion via degradation of SNAP29 to promote virus replication. Autophagy 2022;:1-19. [PMID: 35670302 DOI: 10.1080/15548627.2022.2084686] [Reference Citation Analysis]
32 Chalklin CG, Koimtzis G, Khalid U, Carrington-Windo E, Elker D, Asderakis A. SARS-CoV-2 Infection Can Lead to an Increase in Tacrolimus Levels in Renal Transplant Patients: A Cohort Study. Transpl Int 2022;35:10127. [PMID: 35387396 DOI: 10.3389/ti.2022.10127] [Reference Citation Analysis]
33 Albhaisi S, Wenzel RP. The Value of Medical Registries and Observational Studies Early in Pandemics: The COVID-19 Experience. Clin Infect Dis 2021:ciab634. [PMID: 34270715 DOI: 10.1093/cid/ciab634] [Reference Citation Analysis]
34 Hassan AE. An observational cohort study to assess N-acetylglucosamine for COVID-19 treatment in the inpatient setting. Ann Med Surg (Lond) 2021;68:102574. [PMID: 34306677 DOI: 10.1016/j.amsu.2021.102574] [Reference Citation Analysis]
35 Ren P, Zhu C, He Y, Jiang H, Chen J. Analysis of the dynamic relationship between immune profiles and the clinical features of patients with COVID-19. Ann Transl Med 2021;9:1118. [PMID: 34430559 DOI: 10.21037/atm-21-812] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Wang Y, Fang S, Wu Y, Cheng X, Zhang LK, Shen XR, Li SQ, Xu JR, Shang WJ, Gao ZB, Xia BQ. Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates. Acta Pharmacol Sin 2022;43:781-7. [PMID: 34294887 DOI: 10.1038/s41401-021-00732-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
37 Dong H, Wang S, Zhang J, Zhang K, Zhang F, Wang H, Xie S, Hu W, Gu L. Structure-Based Primer Design Minimizes the Risk of PCR Failure Caused by SARS-CoV-2 Mutations. Front Cell Infect Microbiol 2021;11:741147. [PMID: 34760717 DOI: 10.3389/fcimb.2021.741147] [Reference Citation Analysis]
38 Zhao L, Liu H, Wang Y, Wang S, Xun D, Wang Y, Cheng Y, Zhang B. Multimodal Identification by Transcriptomics and Multiscale Bioassays of Active Components in Xuanfeibaidu Formula to Suppress Macrophage-Mediated Immune Response. Engineering (Beijing) 2021. [PMID: 34815890 DOI: 10.1016/j.eng.2021.09.007] [Reference Citation Analysis]
39 Guo J, Wang S, Xia H, Shi D, Chen Y, Zheng S, Chen Y, Gao H, Guo F, Ji Z, Huang C, Luo R, Zhang Y, Zuo J, Chen Y, Xu Y, Xia J, Zhu C, Xu X, Qiu Y, Sheng J, Xu K, Li L. Cytokine Signature Associated With Disease Severity in COVID-19. Front Immunol 2021;12:681516. [DOI: 10.3389/fimmu.2021.681516] [Reference Citation Analysis]
40 Zhou K, Sun Y, Li L, Zang Z, Wang J, Li J, Liang J, Zhang F, Zhang Q, Ge W, Chen H, Sun X, Yue L, Wu X, Shen B, Xu J, Zhu H, Chen S, Yang H, Huang S, Peng M, Lv D, Zhang C, Zhao H, Hong L, Zhou Z, Chen H, Dong X, Tu C, Li M, Zhu Y, Chen B, Li SZ, Guo T. Eleven routine clinical features predict COVID-19 severity uncovered by machine learning of longitudinal measurements. Comput Struct Biotechnol J 2021;19:3640-9. [PMID: 34188785 DOI: 10.1016/j.csbj.2021.06.022] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Anvar AA, Ahari H, Ataee M. Antimicrobial Properties of Food Nanopackaging: A New Focus on Foodborne Pathogens. Front Microbiol 2021;12:690706. [PMID: 34322104 DOI: 10.3389/fmicb.2021.690706] [Reference Citation Analysis]
42 Deng W, Zeng J, Lu S, Li C. Comprehensive investigation of RNA-sequencing dataset reveals the hub genes and molecular mechanisms of coronavirus disease 2019 acute respiratory distress syndrome. IET Syst Biol 2021. [PMID: 34350693 DOI: 10.1049/syb2.12034] [Reference Citation Analysis]
43 Xiong Y, Tian Y, Ma Y, Liu B, Ruan L, Lu C, Huang L; National Traditional Chinese Medicine Medical Team. The effect of Huashibaidu formula on the blood oxygen saturation status of severe COVID-19: A retrospective cohort study. Phytomedicine 2021;95:153868. [PMID: 34929564 DOI: 10.1016/j.phymed.2021.153868] [Reference Citation Analysis]
44 Scharringa S, Hoffman T, van Kessel DA, Rijkers GT. Vaccination and their importance for lung transplant recipients in a COVID-19 world. Expert Rev Clin Pharmacol 2021;:1-13. [PMID: 34328054 DOI: 10.1080/17512433.2021.1961577] [Reference Citation Analysis]
45 Rinoldi C, Zargarian SS, Nakielski P, Li X, Liguori A, Petronella F, Presutti D, Wang Q, Costantini M, De Sio L, Gualandi C, Ding B, Pierini F. Nanotechnology-Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID-19 Vaccines. Small Methods 2021;:2100402. [PMID: 34514087 DOI: 10.1002/smtd.202100402] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
46 Zheng X, Guo Y, Yang H, Luo L, Ya B, Xu H, Xue Z, Li Q, Shi J, Bi J, Ma W, Wang P. A Cross-Sectional Study on Mental Health Problems of Medical and Nonmedical Students in Shandong During the COVID-19 Epidemic Recovery Period. Front Psychiatry 2021;12:680202. [PMID: 34177663 DOI: 10.3389/fpsyt.2021.680202] [Reference Citation Analysis]
47 Ibrahim D, Kis Z, Tak K, Papathanasiou MM, Kontoravdi C, Chachuat B, Shah N. Model-Based Planning and Delivery of Mass Vaccination Campaigns against Infectious Disease: Application to the COVID-19 Pandemic in the UK. Vaccines (Basel) 2021;9:1460. [PMID: 34960206 DOI: 10.3390/vaccines9121460] [Reference Citation Analysis]
48 Cioffi R, Sabetta G, Rabaiotti E, Bergamini A, Bocciolone L, Candotti G, Candiani M, Valabrega G, Mangili G, Pignata S; MITO group. Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey. Int J Gynecol Cancer 2021;31:1363-8. [PMID: 34426526 DOI: 10.1136/ijgc-2021-002784] [Reference Citation Analysis]
49 Feng Y, Tang K, Lai Q, Liang J, Feng M, Zhou Z, Cui H, Du X, Zhang H, Sun L. The Landscape of Aminoacyl-tRNA Synthetases Involved in Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Front Physiol 2022;12:818297. [DOI: 10.3389/fphys.2021.818297] [Reference Citation Analysis]
50 Vukoja D, Jurić A, Erkapić Z, Pejić T, Zovko Ž, Juričić J, Pejić J, Ćorluka M. Beneficial Treatment Outcomes of Severe COVID-19 Patients Treated Entirely in Primary Care Settings With Dexamethasone Including Regimen-Case Series Report. Front Pharmacol 2021;12:684537. [PMID: 34456719 DOI: 10.3389/fphar.2021.684537] [Reference Citation Analysis]
51 Cui Y, Zhang M, Xu H, Zhang T, Zhang S, Zhao X, Jiang P, Li J, Ye B, Sun Y, Wang M, Deng Y, Meng Q, Liu Y, Fu Q, Lin J, Wang L, Chen Y. Elastase Inhibitor Cyclotheonellazole A: Total Synthesis and In Vivo Biological Evaluation for Acute Lung Injury. J Med Chem 2022. [PMID: 35005973 DOI: 10.1021/acs.jmedchem.1c01583] [Reference Citation Analysis]
52 Onodi F, Bonnet-Madin L, Meertens L, Karpf L, Poirot J, Zhang SY, Picard C, Puel A, Jouanguy E, Zhang Q, Le Goff J, Molina JM, Delaugerre C, Casanova JL, Amara A, Soumelis V. SARS-CoV-2 induces human plasmacytoid pre-dendritic cell diversification via UNC93B and IRAK4. bioRxiv 2021:2020. [PMID: 33442685 DOI: 10.1101/2020.07.10.197343] [Cited by in Crossref: 8] [Article Influence: 8.0] [Reference Citation Analysis]
53 Wang Z, Xiang L, Lin F, Cai Z, Ruan H, Wang J, Liang J, Wang F, Lu M, Cui W. Inhaled ACE2-engineered microfluidic microsphere for intratracheal neutralization of COVID-19 and calming of the cytokine storm. Matter 2021. [PMID: 34693277 DOI: 10.1016/j.matt.2021.09.022] [Reference Citation Analysis]
54 Fukuda Y, Tsugawa T, Nagaoka Y, Ishii A, Nawa T, Togashi A, Kunizaki J, Hirakawa S, Iida J, Tanaka T, Kizawa T, Yamamoto D, Takeuchi R, Sakai Y, Kikuchi M, Nagai K, Asakura H, Tanaka R, Yoshida M, Hamada R, Kawasaki Y. Surveillance in hospitalized children with infectious diseases in Japan: Pre- and post-coronavirus disease 2019. J Infect Chemother 2021:S1341-321X(21)00213-0. [PMID: 34389224 DOI: 10.1016/j.jiac.2021.07.024] [Reference Citation Analysis]
55 Raimondi A, Poma G, Piralla A, Meroni V, Baldanti F, Filice C. Looking for fever in nursing home residents with COVID-19: A false friend? Int J Infect Dis 2021;104:83-4. [PMID: 33359063 DOI: 10.1016/j.ijid.2020.12.052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
56 Wang P, Jin Z, Song G, Zhang X. Recent progress and strategies for precise framework structure-enabled drug delivery systems. Materials Today Sustainability 2021;13:100065. [DOI: 10.1016/j.mtsust.2021.100065] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Zhao Y, Liang X, Chen D, Bian X, Liu W, Han L. Denatured proteins show new vitality: Green synthesis of germanium oxide hollow microspheres with versatile functions by denaturing proteins around bubbles. Aggregate. [DOI: 10.1002/agt2.204] [Reference Citation Analysis]
58 Patel D, Cox BD, Kasthuri M, Mengshetti S, Bassit L, Verma K, Ollinger-Russell O, Amblard F, Schinazi RF. In silico design of a novel nucleotide antiviral agent by free energy perturbation. Chem Biol Drug Des 2022;99:801-15. [PMID: 35313085 DOI: 10.1111/cbdd.14042] [Reference Citation Analysis]
59 Musarra-Pizzo M, Pennisi R, Ben-Amor I, Mandalari G, Sciortino MT. Antiviral Activity Exerted by Natural Products against Human Viruses. Viruses 2021;13:828. [PMID: 34064347 DOI: 10.3390/v13050828] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
60 Tao S, Zandi K, Bassit L, Ong YT, Verma K, Liu P, Downs-Bowen JA, McBrayer T, LeCher JC, Kohler JJ, Tedbury PR, Kim B, Amblard F, Sarafianos SG, Schinazi RF. Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside. Curr Res Pharmacol Drug Discov 2021;2:100045. [PMID: 34870151 DOI: 10.1016/j.crphar.2021.100045] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Russick J, Foy PE, Josseaume N, Meylan M, Hamouda NB, Kirilovsky A, Sissy CE, Tartour E, Smadja DM, Karras A, Hulot JS, Livrozet M, Fayol A, Arlet JB, Diehl JL, Dragon-Durey MA, Pagès F, Cremer I. Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized Medicine. Front Immunol 2021;12:701273. [PMID: 34322128 DOI: 10.3389/fimmu.2021.701273] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Danics K, Pesti A, Törő K, Kiss-Dala N, Szlávik J, Lakatos B, Radnai A, Balázs T, Bacskai M, Dobi D, Várkonyi T, Glasz T, Lotz G, Kiss A, Schaff Z, Vályi-Nagy I. A COVID-19-association-dependent categorization of death causes in 100 autopsy cases. Geroscience 2021;43:2265-87. [PMID: 34510338 DOI: 10.1007/s11357-021-00451-w] [Reference Citation Analysis]
63 Gonzalez BL, de Oliveira NC, Ritter MR, Tonin FS, Melo EB, Sanches ACC, Fernandez-Llimos F, Petruco MV, de Mello JCP, Chierrito D, de Medeiros Araújo DC. The naturally-derived alkaloids as a potential treatment for COVID-19: A scoping review. Phytother Res 2022. [PMID: 35355337 DOI: 10.1002/ptr.7442] [Reference Citation Analysis]
64 Kandimalla R, Chakraborty P, Vallamkondu J, Chaudhary A, Samanta S, Reddy PH, De Feo V, Dewanjee S. Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges. Biomedicines 2021;9:1740. [PMID: 34829969 DOI: 10.3390/biomedicines9111740] [Reference Citation Analysis]
65 Clark JH, Pang S, Naclerio RM, Kashima M. Complications of nasal SARS-CoV-2 testing: a review. J Investig Med 2021:jim-2021-001962. [PMID: 34348963 DOI: 10.1136/jim-2021-001962] [Reference Citation Analysis]
66 McCoy K, Gudapati S, He L, Horlander E, Kartchner D, Kulkarni S, Mehra N, Prakash J, Thenot H, Vanga SV, Wagner A, White B, Mitchell CS. Biomedical Text Link Prediction for Drug Discovery: A Case Study with COVID-19. Pharmaceutics 2021;13:794. [PMID: 34073456 DOI: 10.3390/pharmaceutics13060794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 He Y, Qi J, Xiao L, Shen L, Yu W, Hu T. Purification and characterization of the receptor-binding domain of SARS-CoV-2 spike protein from Escherichia coli. Eng Life Sci 2021;21:453-60. [PMID: 34140855 DOI: 10.1002/elsc.202000106] [Reference Citation Analysis]
68 Dai T, Zhang L, Dai X, Zhang X, Lu B, Zheng Y, Shen D, Yan Y, Ji C, Yu J, Sun L. Multimode participation of traditional Chinese medicine in the treatment of COVID-19. Integr Med Res 2021;10:100781. [PMID: 34642626 DOI: 10.1016/j.imr.2021.100781] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Panagiotopoulos A, Tseliou M, Karakasiliotis I, Kotzampasi DM, Daskalakis V, Kesesidis N, Notas G, Lionis C, Kampa M, Pirintsos S, Sourvinos G, Castanas E. p-cymene impairs SARS-CoV-2 and Influenza A (H1N1) viral replication: In silico predicted interaction with SARS-CoV-2 nucleocapsid protein and H1N1 nucleoprotein. Pharmacol Res Perspect 2021;9:e00798. [PMID: 34128351 DOI: 10.1002/prp2.798] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Fründt T, Kuballa L, Lütgehetman M, Nörz D, Arend H, Brehm TT, Schulze Zur Wiesch J, Horvatits T, Horvatits K, Huber S, Wege H, Kluwe J. Low incidence of COVID-19 in a prospective cohort of patients with liver cirrhosis and hepatocellular carcinoma treated at a tertiary medical center during the 2020 pandemic. PLoS One 2021;16:e0258450. [PMID: 34941875 DOI: 10.1371/journal.pone.0258450] [Reference Citation Analysis]
71 Elhence A, Vaishnav M, Biswas S, Chauhan A, Anand A, Shalimar. Coronavirus Disease-2019 (COVID-19) and the Liver. J Clin Transl Hepatol 2021;9:247-55. [PMID: 34007807 DOI: 10.14218/JCTH.2021.00006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Lai Y, Han T, Lao Z, Li G, Xiao J, Liu X. Phillyrin for COVID-19 and Influenza Co-infection: A Potential Therapeutic Strategy Targeting Host Based on Bioinformatics Analysis. Front Pharmacol 2021;12:754241. [PMID: 34803696 DOI: 10.3389/fphar.2021.754241] [Reference Citation Analysis]
73 Zhussupov B, Saliev T, Sarybayeva G, Altynbekov K, Tanabayeva S, Altynbekov S, Tuleshova G, Pavalkis D, Fakhradiyev I. Analysis of COVID-19 pandemics in Kazakhstan. J Res Health Sci 2021;21:e00512. [PMID: 34465636 DOI: 10.34172/jrhs.2021.52] [Reference Citation Analysis]
74 Reyaz S, Tasneem A, Rai GP, Bairagya HR. Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study. J Mol Graph Model 2021;109:108021. [PMID: 34537554 DOI: 10.1016/j.jmgm.2021.108021] [Reference Citation Analysis]
75 Ren X, Shen F, Gui Y, Wang W, Xing B, Huang W. The attitudes of psychiatric patients towards COVID-19 vaccination in China: a cross-sectional study. BMC Psychiatry 2021;21:475. [PMID: 34587935 DOI: 10.1186/s12888-021-03484-9] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
76 Shirazi S, Stanford CM, Cooper LF. Characteristics and Detection Rate of SARS-CoV-2 in Alternative Sites and Specimens Pertaining to Dental Practice: An Evidence Summary. J Clin Med 2021;10:1158. [PMID: 33802043 DOI: 10.3390/jcm10061158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
77 Ding ZY, Li GX, Shu C, Yin P, Zhang B; Tongji multidisciplinary Team for Treating COVID-19 (TTTC). Reply to: Comments on "Association of liver abnormalities with in-hospital mortality in patients with COVID-19". J Hepatol 2021;75:742-4. [PMID: 34090927 DOI: 10.1016/j.jhep.2021.05.027] [Reference Citation Analysis]
78 Moradi G, Mohamadi Bolbanabad A, Ahmadi S, Aghaei A, Bahrami F, Veysi A, Nasiri Kalmarzi R, Shokri A, Ghaderi E, Mohsenpour B, Mohammadi A. Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study. Int Immunopharmacol 2021;98:107893. [PMID: 34174700 DOI: 10.1016/j.intimp.2021.107893] [Reference Citation Analysis]
79 Ibrahim EH, Alshahrani MY, Ghramh HA, Kilany M. Antibody profile in symptomatic/asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected Saudi persons. Saudi J Biol Sci 2021;28:4677-82. [PMID: 33967583 DOI: 10.1016/j.sjbs.2021.04.080] [Reference Citation Analysis]
80 Quan Y, Li L, Yin Z, Chen S, Yi J, Lang J, Zhang L, Yue Q, Zhao J. Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19? Front Pharmacol 2022;12:784335. [DOI: 10.3389/fphar.2021.784335] [Reference Citation Analysis]
81 Rehati P, Amaerjiang N, Yang L, Xiao H, Li M, Zunong J, Wang L, Vermund SH, Hu Y. COVID-19 Vaccine Hesitancy among Adolescents: Cross-Sectional School Survey in Four Chinese Cities Prior to Vaccine Availability. Vaccines 2022;10:452. [DOI: 10.3390/vaccines10030452] [Reference Citation Analysis]
82 Yuyun X, Lexi Y, Haochu W, Zhenyu S, Xiangyang G. Early Warning Information for Severe and Critical Patients With COVID-19 Based on Quantitative CT Analysis of Lung Segments. Front Public Health 2021;9:596938. [PMID: 34055706 DOI: 10.3389/fpubh.2021.596938] [Reference Citation Analysis]
83 Li J, Sczepanski JT. Targeting a conserved structural element from the SARS-CoV-2 genome using l -DNA aptamers. RSC Chem Biol 2022;3:79-84. [DOI: 10.1039/d1cb00172h] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Cichoż-Lach H, Michalak A. Liver injury in the era of COVID-19. World J Gastroenterol 2021; 27(5): 377-390 [PMID: 33584070 DOI: 10.3748/wjg.v27.i5.377] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
85 Yoon W, Park Y, Kim S, Bang IS. Development of an Oral Salmonella-Based Vaccine Platform against SARS-CoV-2. Vaccines (Basel) 2022;10:67. [PMID: 35062728 DOI: 10.3390/vaccines10010067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Zhao Z, Xiao Y, Xu L, Liu Y, Jiang G, Wang W, Li B, Zhu T, Tan Q, Tang L, Zhou H, Huang X, Shan H. Glycyrrhizic Acid Nanoparticles as Antiviral and Anti-inflammatory Agents for COVID-19 Treatment. ACS Appl Mater Interfaces 2021;13:20995-1006. [PMID: 33930273 DOI: 10.1021/acsami.1c02755] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
87 Zhan Y, Li XP, Yin JY. COVID-19 one year later: a retrospect of CRISPR-Cas system in combating COVID-19. Int J Biol Sci 2021;17:2080-8. [PMID: 34131407 DOI: 10.7150/ijbs.60655] [Reference Citation Analysis]
88 Sirinawasatien A, Chantarojanasiri T, Ekpanyapong S, Tivatunsakul N, Luvira V. Coronavirus disease 2019 gastrointestinal and liver manifestations in adults: A review. JGH Open 2021;5:1257-65. [PMID: 34816011 DOI: 10.1002/jgh3.12671] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Figueroa-Pizano MD, Campa-Mada AC, Carvajal-Millan E, Martinez-Robinson KG, Chu AR. The underlying mechanisms for severe COVID-19 progression in people with diabetes mellitus: a critical review. AIMS Public Health 2021;8:720-42. [PMID: 34786431 DOI: 10.3934/publichealth.2021057] [Reference Citation Analysis]
90 de Vries MP, Mohammadnia N, Simsek S, Schoorl M. Eosinopenia and increased markers of endothelial damage are characteristic of COVID-19 infection at time of hospital admission. Scand J Clin Lab Invest 2022;:1-6. [PMID: 35621384 DOI: 10.1080/00365513.2022.2079095] [Reference Citation Analysis]
91 Tang G, Zhang L, Huang W, Wei Z. Could Immunonutrition Help in the Fight against COVID-19 in Cancer Patient? Nutr Cancer 2021;:1-10. [PMID: 34309463 DOI: 10.1080/01635581.2021.1957128] [Reference Citation Analysis]
92 Li L, Huang S. Newly synthesized Mpro inhibitors as potential oral anti-SARS-CoV-2 agents. Signal Transduct Target Ther 2021;6:138. [PMID: 33790219 DOI: 10.1038/s41392-021-00560-0] [Reference Citation Analysis]
93 Deng H, Yan X, Yuan L. Human genetic basis of coronavirus disease 2019. Signal Transduct Target Ther 2021;6:344. [PMID: 34545062 DOI: 10.1038/s41392-021-00736-8] [Reference Citation Analysis]
94 Lv J, Wang Z, Qu Y, Zhu H, Zhu Q, Tong W, Bao L, Lv Q, Cong J, Li D, Deng W, Yu P, Song J, Tong WM, Liu J, Liu Y, Qin C, Huang B. Distinct uptake, amplification, and release of SARS-CoV-2 by M1 and M2 alveolar macrophages. Cell Discov 2021;7:24. [PMID: 33850112 DOI: 10.1038/s41421-021-00258-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
95 Zhu H, Zhang L, Ma Y, Zhai M, Xia L, Liu J, Yu S, Duan W. The role of SARS-CoV-2 target ACE2 in cardiovascular diseases. J Cell Mol Med 2021;25:1342-9. [PMID: 33443816 DOI: 10.1111/jcmm.16239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
96 Zhou YW, Xie Y, Tang LS, Pu D, Zhu YJ, Liu JY, Ma XL. Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies. Signal Transduct Target Ther 2021;6:317. [PMID: 34446699 DOI: 10.1038/s41392-021-00733-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
97 Chu L, Huang F, Zhang M, Huang B, Wang Y. Current status of traditional Chinese medicine for the treatment of COVID-19 in China. Chin Med 2021;16:63. [PMID: 34315521 DOI: 10.1186/s13020-021-00461-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
98 Jiménez D, Torres Arias M. Immunouniverse of SARS-CoV-2. Immunol Med 2022;:1-39. [PMID: 35502127 DOI: 10.1080/25785826.2022.2066251] [Reference Citation Analysis]
99 Gu W, Gan H, Ma Y, Xu L, Cheng ZJ, Li B, Zhang X, Jiang W, Sun J, Sun B, Hao C. The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity. Virol J 2022;19. [DOI: 10.1186/s12985-022-01783-5] [Reference Citation Analysis]
100 Liu N, Zhang Y, Lei Y, Wang R, Zhan M, Liu J, An Y, Zhou Y, Zhan J, Yin F, Li Z. Design and Evaluation of a Novel Peptide-Drug Conjugate Covalently Targeting SARS-CoV-2 Papain-like Protease. J Med Chem 2022;65:876-84. [PMID: 34981929 DOI: 10.1021/acs.jmedchem.1c02022] [Reference Citation Analysis]
101 Kordyukova LV, Shanko AV. COVID-19: Myths and Reality. Biochemistry (Mosc) 2021;86:800-17. [PMID: 34284707 DOI: 10.1134/S0006297921070026] [Reference Citation Analysis]
102 Chakravarty N, Senthilnathan T, Paiola S, Gyani P, Castillo Cario S, Urena E, Jeysankar A, Jeysankar P, Ignatius Irudayam J, Natesan Subramanian S, Lavretsky H, Joshi S, Garcia G Jr, Ramaiah A, Arumugaswami V. Neurological pathophysiology of SARS-CoV-2 and pandemic potential RNA viruses: a comparative analysis. FEBS Lett 2021. [PMID: 34757622 DOI: 10.1002/1873-3468.14227] [Reference Citation Analysis]
103 Wang Y, Chen XY, Yang L, Yao Q, Chen KP. Human SARS-CoV-2 has evolved to increase U content and reduce genome size. Int J Biol Macromol 2022:S0141-8130(22)00270-7. [PMID: 35149094 DOI: 10.1016/j.ijbiomac.2022.02.034] [Reference Citation Analysis]
104 Balthazar JA, Chehter EZ. Acute pancreatitis and COVID-19: a new target for infection? Einstein (São Paulo) 2022;20:eRW6667. [DOI: 10.31744/einstein_journal/2022rw6667] [Reference Citation Analysis]
105 Grygiel-Górniak B, Shaikh O, Kumar NN, Hsu SH, Samborski W. Use of the rheumatic drug tocilizumab for treatment of SARS-CoV-2 patients. Reumatologia 2021;59:252-9. [PMID: 34538956 DOI: 10.5114/reum.2021.108554] [Reference Citation Analysis]
106 Yang CC, Wu CJ, Chien CY, Chien CT. Green Tea Polyphenol Catechins Inhibit Coronavirus Replication and Potentiate the Adaptive Immunity and Autophagy-Dependent Protective Mechanism to Improve Acute Lung Injury in Mice. Antioxidants (Basel) 2021;10:928. [PMID: 34200327 DOI: 10.3390/antiox10060928] [Reference Citation Analysis]
107 Nakayoshi T, Kato K, Kurimoto E, Oda A. Virtual Alanine Scan of the Main Protease Active Site in Severe Acute Respiratory Syndrome Coronavirus 2. Int J Mol Sci 2021;22:9837. [PMID: 34576002 DOI: 10.3390/ijms22189837] [Reference Citation Analysis]
108 Onodi F, Bonnet-Madin L, Meertens L, Karpf L, Poirot J, Zhang SY, Picard C, Puel A, Jouanguy E, Zhang Q, Le Goff J, Molina JM, Delaugerre C, Casanova JL, Amara A, Soumelis V. SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4. J Exp Med 2021;218:e20201387. [PMID: 33533916 DOI: 10.1084/jem.20201387] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 23.0] [Reference Citation Analysis]
109 . Pharmacological activation of STING blocks SARS-CoV-2 infection. Sci Immunol 2021;6:eabi9007. [PMID: 34010142 DOI: 10.1126/sciimmunol.abi9007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
110 Wu R, Luo KQ. Developing effective siRNAs to reduce the expression of key viral genes of COVID-19. Int J Biol Sci 2021;17:1521-9. [PMID: 33907515 DOI: 10.7150/ijbs.59151] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
111 Dhakal A, McKay C, Tanner JJ, Cheng J. Artificial intelligence in the prediction of protein-ligand interactions: recent advances and future directions. Brief Bioinform 2021:bbab476. [PMID: 34849575 DOI: 10.1093/bib/bbab476] [Reference Citation Analysis]
112 Satoh T, Trudler D, Oh C, Lipton SA. Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome. Antioxidants 2022;11:124. [DOI: 10.3390/antiox11010124] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
113 Gerbier E, Favre G, Tauqeer F, Winterfeld U, Stojanov M, Oliver A, Passier A, Nordeng H, Pomar L, Baud D, Panchaud A, Meyer-Massetti C, Ceulemans M. Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study. Int J Environ Res Public Health 2022;19:5335. [PMID: 35564733 DOI: 10.3390/ijerph19095335] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
114 Gong F, Wei HX, Li Q, Liu L, Li B. Evaluation and Comparison of Serological Methods for COVID-19 Diagnosis. Front Mol Biosci 2021;8:682405. [PMID: 34368226 DOI: 10.3389/fmolb.2021.682405] [Cited by in F6Publishing: 1] [Reference Citation Analysis]